Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

[Lys61]N-Ras is able to induce full activation and nuclear accumulation of Cdk4 in NIH3T3 cells

Abstract

The elements of the cell cycle regulatory machinery activated by the oncogenic form of Ras, [Lys61]N-Ras, have been analysed in NIH3T3 cells. We demonstrate that [Lys61]N-Ras expression is able to induce full cdk4 activation. As already reported, oncogenic Ras expression was sufficient to induce cyclin D1 and p21cip1 expression and their association with cdk4. Furthermore, serum-starved [Lys61]N-Ras NIH3T3 cells showed nuclear accumulation of cyclin D1 and cdk4 not observed in serum-starved NIH3T3 cells. This accumulation of cdk4 into the cell nucleus observed in serum-starved [Lys61]N-Ras NIH3T3 cells was inhibited by a microinjection of neutralizing anti-Ras antibodies. Thus, active [Lys61]N-Ras was a sufficient signal to induce nuclear accumulation of cyclin D1/cdk4, leading to its full activation. Transfection of [Lys61]N-Ras NIH3T3 cells with an inactive form of MEK or their treatment with PD 98059, showed that nuclear translocation of cdk4 was MEK dependent. Interestingly, cells constitutively expressing [Lys61]N-Ras did not inactivate pRb and did not proliferate in the absence of serum. This may be due to the fact that although association of cdk2 with cyclin E and the translocation of those complexes to the nucleus were achieved, [Lys61]N-Ras expression was not sufficient to induce cdk2 activation. The high levels of p27kip1 that were found in cyclin E/cdk2 complexes may be responsible for the inability of oncogenic Ras to activate this kinase. In consequence, oncogenic alterations that lead to a decrease in p27kip1 bound to cyclin E may cooperate with Ras to induce full cdk2 activation, pRb inactivation and thus cell proliferation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Aktas H, Cai H and Cooper GM. . 1997 Mol. Cell Biol. 17: 3850–3857.

  • Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A and Pestell RG. . 1995 J. Biol. Chem. 270: 23589–23597.

  • Arber N, Doki Y, Han EK, Sgambato A, Zhou P, Kim NH, Delohery T, Klein MG, Holt PR and Weinstein IB. . 1997 Cancer Res. 57: 1569–1574.

  • Barbacid M. . 1987 Annu. Rev. Biochem. 56: 779–827.

  • Blain SW, Montalvo E and Massague J. . 1997 J. Biol. Chem. 272: 25863–25872.

  • Bos JL. . 1989 Cancer Res. 49: 4682–4689.

  • Bosch M, Gil J, Bachs O and Agell N. . 1998 J. Biol. Chem. 273: 22145–22150.

  • Botz J, Zerfass-Thome K, Spitkovsky D, Delius H, Vogt B, Eilers M, Hatzigeorgion A and Jansen-Durr P. . 1996 Mol. Cell. Biol. 16: 3401–3409.

  • Bradford MM. . 1976 Anal. Biochem. 72: 248–254.

  • Cheng M, Sexl V, Sherr CJ and Roussel MF. . 1998 Proc. Natl. Acad. Sci. USA 95: 1091–1096.

  • Dalton S. . 1992 EMBO J. 11: 1797–1804.

  • Davis RJ. . 1993 J. Biol. Chem. 268: 14553–14556.

  • de Rooij J and Bos JL. . 1997 Oncogene 14: 623–625.

  • Diehl JA, Cheng MG, Roussel MF and Sherr CJ. . 1998 Genes Devel. 12: 3499–3511.

  • Dobrowolski S, Harter M and Stacey DW. . 1994 Mol. Cell Biol. 14: 5441–5449.

  • Dong F, Cress-WD J, Agrawal D and Pledger WJ. . 1998 J. Biol. Chem. 273: 6190–6195.

  • Dou Q, Zhao S, Levin A, Wang J, Helin K and Pardee A. . 1994 J. Biol. Chem. 269: 1306–1313.

  • Downward J. . 1997 Curr. Biol. 7: R258–R260.

  • Downward J. . 1998 Curr. Opin. Genet. Dev. 8: 49–54.

  • Draetta G. . 1994 Curr. Opin. Cell Biol. 6: 842–846.

  • Feramisco JR, Gross M, Kamata T, Rosenberg M and Sweet RW. . 1984 Cell 38: 109–117.

  • Geng Y, Eaton EN, Picon M, Roberts JM, Sardet C and Weinberg RA. . 1996 Oncogene 12: 1173–1180.

  • Grana X and Reddy EP. . 1995 Oncogene 11: 211–219.

  • Harlow E and Lane D. . 1988 Cold Spring Laboratory Press.

  • Harper JW, Adami G, Wei N, Keyomarsi K and Elledge SJ. . 1993 Cell 75: 805–816.

  • Jin P, Hardy S and Morgan DO. . 1998 J. Cell Biol. 141: 875–885.

  • Jinno S, Suto K, Nagata A, Igarashi M, Kanaoka Y, Nojima H and Okayama H. . 1994 EMBO J. 13: 1549–1556.

  • Kato J, Matsuoka M, Polyak K, Massagué J and Sherr C. . 1994b Cell 79: 487–496.

  • Kato J, Matsuoka M, Strom DK and Sherr CJ. . 1994a Mol. Cell. Biol. 14: 2713–2721.

  • Katz ME and McCormick F. . 1997 Curr. Opin. Genet. Dev. 7: 75–79.

  • Kerkhoff E and Rapp UR. . 1998 Oncogene 17: 1457–1462.

  • Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ and Pardee AB. . 1994 Cancer Res. 54: 380–385.

  • La Baer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu CH, Chou HS, Fattaey A and Harlow E. . 1997 Genes Devel. 11: 847–862.

  • Laemmli UK. . 1970 Nature 227: 680–685.

  • Lam E and La Thangue N. . 1994 Curr. Opin. Cell Biol. 6: 859–866.

  • Lavoie JN, Lallemain G, Brunet A, Muller R and Pouyssegur J. . 1996 J. Biol. Chem. 271: 20608–20616.

  • Leone G, DeGregori J, Sears R, Jakoi L and Nevins JR. . 1997 Nature 387: 422–426.

  • Lewis TS, Shapiro PS and Ahn NG. . 1998 Adv. Cancer Res. 74: 49–139.

  • Liu JJ, Chao JR, Jiang MC, Ng SY, Yen JJ and Yang YH. . 1995 Mol. Cell Biol. 15: 3654–3663.

  • Liu Y, Martindale JL, Gorospe M and Holbrook NJ. . 1996 Cancer Res. 56: 31–35.

  • Lloyd AC. . 1998 Curr. Opin. Genet. Dev. 8: 43–48.

  • Lundberg AS and Weinberg RA. . 1998 Mol. Cell Biol. 18: 753–761.

  • Marshall CJ. . 1996 Curr. Opin. Cell Biol. 8: 197–204.

  • McCormick F. . 1994 Curr. Opin. Genet. Dev. 4: 71–76.

  • Mittnacht S. . 1998 Curr. Opin. Genet. Deve. 8: 21–27.

  • Mittnacht S, Paterson H, Olson MF and Marshall CJ. . 1997 Curr. Biol. 7: 219–221.

  • Morgan DO. . 1997 Ann. Rev. Cell Dev. Biol. 13: 261–291.

  • Morgan D. . 1995 Nature 374: 131–134.

  • Mulcahy LS, Smith MR and Stacey DW. . 1985 Nature 313: 241–243.

  • Norbury C and Nurse P. . 1992 Annu. Rev. Biochem. 61: 441–470.

  • Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM and Pagano M. . 1995 Mol. Cell Biol. 15: 2612–2624.

  • Olson MF, Paterson HF and Marshall CJ. . 1998 Nature 394: 295–299.

  • Pardee AB. . 1989 Science 246: 447–458.

  • Parry SB, Bates S, Mann DJ and Peters G. . 1995 EMBO J. 14: 503–511.

  • Peeper DS and Bernards R. . 1997 FEBS Lett. 410: 11–16.

  • Peeper DS, Upton TM, Ladha MH, Neuman E, Zalvide J, Bernards R, DeCaprio JA and Ewen ME. . 1997 Nature 386: 177–181.

  • Polyak K, Lee M-H, Erdjument-Bromage H, Tempst P and Massagué J. . 1994 Cell 78: 59–66.

  • Quelle DE, Ashmun RA, Hannon GJ, Rehberger PA, Trono D, Richter KH, Walker C, Beach D, Sherr CJ and Serrano M. . 1995 Oncogene 11: 635–645.

  • Reed SI. . 1992 Annu. Rev. Cell Biol. 8: 529–561.

  • Resnitzky D and Reed DS. . 1995 Mol. Cell. Biol. 15: 3463–3469.

  • Robinson MJ and Cobb MH. . 1997 Curr. Opin. Cell Biol. 9: 180–186.

  • Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD and Downward J. . 1994 Nature 370: 527–532.

  • Roussel MF. . 1998 Adv. Cancer Res. 74: 1–24.

  • Sherr CJ. . 1994 Cell 79: 551–555.

  • Sherr CJ and Roberts J. . 1995 Genes Devel. 9: 1149–1163.

  • Takuwa N and Takuwa Y. . 1997 Mol. Cell Biol. 17: 5348–5358.

  • Taules M, Rius E, Talaya D, Lopez GA, Bachs O and Agell N. . 1998 J. Biol. Chem. 273: 33279–33286.

  • van-Weeren PC, de-Bruyn KM, de-Vries-Smits AM, van-Lint J and Burgering BM. . 1998 J. Biol. Chem. 273: 13150–13156.

  • Vlach J, Hennecke S, Alevizopoulos K, Conti D and Amati B. . 1996 EMBO J. 15: 6595–6604.

  • Vlach J, Hennecke S and Amati B. . 1997 EMBO J. 16: 5334–5344.

  • Weber JD, Hu W, Jefcoat-SCJ, Raben DM and Baldassare JJ. . 1997 J. Biol. Chem. 272: 32966–32971.

  • Winston JT, Coats SR, Wang YZ and Pledger WJ. . 1996 Oncogene 12: 127–134.

  • Zwicker J, Lucibello F, Wolfraim L, Gross C, Truss M, England K and Muller K. . 1995 EMBO J. 14: 4514–4522.

Download references

Acknowledgements

We thank Dr Timothy Thompson (Barcelona) for the gift of the [Lys61]N-Ras NIH3T3 cell line, Dr Joan Massagué (New York) for the gift of anti-p27 antibodies and Dr Piero Crespo for the gift of pcDNAIII-MEKA. We are also grateful to Dr FR McKenzie (Nice) for the gift of GST-RBD plasmid and the advice in the Ras activity analysis, and to Dr Albert Tauler and Silvia Fernández (Barcelona) for helping in CsCl plasmid purification. We also thank Anna Bosch (Serveis Científico-Tècnics, Universitat de Barcelona, Campus Medicina, IDIBAPS) for the technical assistance in confocal microscopy and Dr Pablo Engel and Isabel Sánchez (Barcelona) for helping in FACS analysis. This work was supported by CICYT grants SAF95-0041-C02-02 and SAF97-0069. Priam Villalonga is a recipient of a pre-doctoral fellowship from the CIRIT.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Villalonga, P., Rius, E., Bachs, O. et al. [Lys61]N-Ras is able to induce full activation and nuclear accumulation of Cdk4 in NIH3T3 cells. Oncogene 19, 690–699 (2000). https://doi.org/10.1038/sj.onc.1203341

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203341

Keywords

This article is cited by

Search

Quick links